Finding Genius Podcast

Joshua Perry, keto consultant, former professional athlete, coach, and brain tumor survivor, (joshperrybmx.com) talks about his life and work as a keto consultant and public speaker. Perry provides some background on his life and interests, starting out with his high school years, and how he found a love for BMX (bike motocross). He talks in-depth about his competition years, and how regular pain, nausea, and vision loss caused him to look deeper into his health issues. He explains the difficult process and path that led to the discovery he had a brain problem that had to be dealt with. He explains the process, from diagnosis to surgery, and how he coped along the way. Moving forward, he sought a way to improve his life, after the brain tumor surgery, and he found keto. He discusses physicians and his feelings about medicine in general, discussing his aversion to taking regular pain meds, etc. As he explains, diet and nutrition are the key elements he focuses on to maximize his health. As a keto consultant, Perry has clients all over the globe. Perry utilizes communication and a results-oriented program to help clients increase cognitive function, enhance their quality of life, and bring their overall performance and health to the highest level possible. Wrapping up, Perry talks about how to prioritize, and focus the brain, and he discusses the many types of people he interacts with and coaches.

Paula Baker-Laporte FAIA, Architect, EcoNest Architecture Inc. Healthy Home Design and Consulting, discusses her important work in the emerging arena of healthy, green architecture. Baker-Laporte holds degrees from the School of Architecture at the University of Toronto, and The International Institute of Bau-Biologie and Ecology. Baker-Laporte's firm is dedicated to environmentally sound and health-enhancing architecture. She is a noted advocate for environmentally-sound architecture and was recognized as a United States 'Top 10' green architect by Natural Home magazine. Baker-Laporte discusses her interest in 'healthy' architecture. She talks about her personal background and her incredible sensitivity to various chemicals that negatively impacted her health. As she states, after battling pneumonia literally every year, and her regular bouts with dizziness and her general loss of focus, she began to dig deeper into how our environments, specifically architecture, can greatly impact our health and wellness. The recognized architect discusses the many problems that homes can have, from mold to chemicals to electromagnetic radiation. She talks about the ways we can improve our living environments, and begin to rid our homes of the negatively impacting agents. From standalone filtration systems, to reorganizing how you use your space (considering where you are sleeping), to vacuuming and cleaning practices and solutions, to simply opening windows, she discusses it all. Baker-Laporte was elected into the College of Fellows of the American Institute of Architects, recognized for her groundbreaking architectural and educational work in the emerging area of Natural Healthy Building.

Cass Nelson-Dooley, M.S., owner and CEO of Health First Consulting, LLC, discusses her work and research into the microbiome and beyond. Nelson-Dooley has conducted extensive research into the pharmacology of medicinal plants at the University of Georgia and AptoTec, Inc, and she was an innovator at Metametrix Clinical Laboratory as well as Genova Diagnostics. Nelson-Dooley is passionate about human health, passionate about improving it through a comprehensive approach that addresses the many and various underlying causes of disease. She is a student of ethnobotany, ethnopharmacology, and natural product chemistry and has experience in integrative and functional medicine, and the integrative medicine laboratory industry, as well as nutraceutical research and development, osteoporosis, and obesity. Nelson-Dooley discusses her background and her desire to learn all she could about medicinal plants. Natural medicine, as she explains, has long been something she and her family were interested in. She discusses her work and time in Panama, studying indigenous people and the plants that they used for common illnesses. Nelson-Dooley's book, Heal Your Oral Microbiome: Balance and Repair your Mouth Microbes to Improve Gut Health, Reduce Inflammation and Fight Disease, is a good read for anyone who wants to seriously work on improving their health. Nelson-Dooley explains how plants need vitamins and minerals, and she discusses the many similarities of living organisms. She outlines the nutrients that plants have within them that we as humans could harness and take advantage of. Continuing, she explains some of the problems that occur with modern drugs on the market. Nelson-Dooley discusses her evolutionary perspective on why certain plants do what they do, and how they continually work to advance their lineage. She cites the example of the fruit tree, and how it is perfectly designed to promote its survival, as fruits are eaten and then the fruit seed is carried and deposited through feces, which creates a perfect environment for the growth of a new tree. Continuing, Nelson-Dooley discusses her book and microbiome testing, including her work in diagnostic testing. She talks about the gut microbiome in detail and explains her research into the oral microbiome. She explains the similarities between the two. And she talks about the many functions of the microbiome, from making vitamins to calming inflammation.

Alan K. Davis, PhD, of the Center for Psychedelic and Consciousness Research at Johns Hopkins University, discusses his important work researching the powerful and positive effects of psilocybin on depression sufferers. Dr. Davis has vast clinical experience in multiple areas and he regularly works with people who are dealing with trauma-based psychological problems, including addiction, PTSD, depression, and anxiety. Dr. Davis discusses his research, and his work as a guide for psychedelic-assisted psychotherapy for people suffering from depression. The doctor's work focuses on psychedelic research that includes clinical trials with psilocybin (the active psychedelic ingredient in "magic mushrooms") for people with depression. His research explores the many psychological mechanisms through which the psilocybin can potentially ameliorate mental health and functioning. Remarkably, approximately 50% of the people who participated in their study stated that their depression was completely eradicated after about one month of treatment. And following up, at the three and six month marks, Dr. Davis states that a good number of those people are still free of depression entirely. Dr. Davis explains their treatment process and how actual psychotherapy is an integral part. As he states, it's important to build a rapport with study participants and create a level of trust, so they are comfortable with the environment and the process. Dr. Davis talks about some of the upcoming trials and the data that the FDA will need to approve the psilocybin as a specialty drug that can be prescribed by psychiatrists or general practice doctors and then administered by psychologists, social workers, and counselors. Dr. Davis discusses some of the states that are working to push legislative changes, and how the DEA is involved with the scheduling of the drug. Continuing, Dr. Davis discusses in detail the mechanisms that allow psilocybin to work. As he states, the psilocybin takes action on serotonin, a neurotransmitter in the brain. Dr. Davis explains that serotonin is the chemical in the brain that regulates many things such as mood, appetite, and sleep. And as depression sufferers often experience negative mood, decreased or increased appetite, and sleep disruption, psilocybin is potentially a great alternative for depression, especially for those people who have found no relief through other meds that are typically prescribed for depression.

In this episode, we hear from Dr. Lynelle Schneeberg, sleep psychologist and assistant professor of clinical psychiatry at Yale School of Medicine. Dr. Schneeberg works with adults who suffer from sleeping disorders and helps educate and coach guardians of children who struggle with sleep. Today's conversation is focused on helping babies and children to have better sleep health. Dr. Schneeberg tells us that the most common sleep challenge for children is behavioral insomnia, which may be caused by learned methods of falling asleep—methods that aren't necessarily ideal. Click play to hear her discuss her new book, Become Your Child's Sleep Coach: The Bedtime Doctor's 5 Step Guide, Ages 3-10, and learn her general tips for raising healthy sleepers.

Louise Charles, Communications Manager at Climeworks (climeworks.com), provides an overview of how Climeworks' technology is helping with CO2 removal from the atmosphere. Louise is a multilingual, expert communications specialist with vast experience working cross-culturally in communications, project management, as well as translation. Louise discusses the history and founding of Climeworks and how it has grown to a company of seventy employees to date. Louise discusses their innovative CO2 collectors, and how their system's fans draw in the air and filter it. As climate change is driven by the activities of humans, through the burning of fossil fuels that release dangerous levels of carbon dioxide into the air that are directly causing global warming, Climeworks' technology seeks to help with CO2 removal from the atmosphere. Climate change desperately needs advanced carbon removal technologies and this is where Climeworks is stepping up to meet the challenge, because climate scenarios have demonstrated that negative emissions will be necessary in order to keep global warming below critical levels. The Communications Manager talks about the many ways that they can utilize the collected CO2 in various other uses for multiple industries. She explains their storage options and the economic options for countries who are utilizing the CO2 collection technology. Continuing, Louise expounds upon the rewards systems that parties can take advantage of when they provide information on their offset emissions. She talks about the costs of CO2 capture, as well their goals for decreasing costs in the future as they streamline and expand. Wrapping up, the technology expert and Communications Manager talks about their larger projects that capture even greater amounts of CO2, possibly even millions of tons. And she discusses the Climeworks timeline and their goals for CO2 capture as they expand their operations. Climeworks' expansion of the world's first commercial carbon removal technology will hopefully lead us to a negative emissions future that will be better for the planet and the living organisms, including us, who reside upon it.

Edward Sawicki Jr., MBA, Chief Executive Officer at Think20 Labs, LLC (think20labs.com), discusses his vision for the future of cannabis. Sawicki's mission is to help expand personalized medicine and ensure safety for consumers in the cannabis market. He is a cannabis advocate and is heavily involved in the education of consumers about the many benefits of cannabis. Sawicki has a rich background in the biotech space assisting with lab design for DNA-sequencing and molecular biology labs. Sawicki talks about the premise of Think20 Labs and his background. He explains that Think20 Labs is much more than a testing company, that his company wants to encompass everything they know about molecular development and beyond. Think20 Labs is heavily involved in not only compliance testing, but the sequencing of DNA, epigenetic work, and so much more in research, and the design of projects as well. Sawicki explains that Think20 Labs seeks to get to the core of what cannabis can truly do to move medicine forward and help individuals who suffer from a wide variety of maladies. As he explains, full legalization is needed in order to expand the research. The cannabis research expert talks about the individualized work they do with local growers, and the massive data that they are collecting about plants and soil conditions, etc. As he states, the most important issue right now is ensuring safety for consumers, and compliance. He discusses the dangers of products that come from the black market, and how full legalization with standards will help to improve safety. Wrapping up, he talks about how research into epigenomic and RNA profiles will help them to figure out where the important correlations lie, in regard to understanding what they need to learn, and how to approach that in an ordered fashion. Sawicki states that by starting with genetic profiles of patients and of plants, their research can begin to find important correlations that will guide further research, ongoing.

Sean Buchanan, co-founder of Visom Technology, Inc. (visomtech.com), talks in detail about the incredible AR + AI software-enabled technology that his company offers. Visom's mission is to enable surgery without any compromise whatsoever. By bringing together AR + AI software, Visom is innovating how surgeons can see and operate, by overlaying important images directly over patients which places crucial information surgeons need right in their easy view. Buchanan talks about Visom's mission in detail, discussing Augmented Reality (AR). As he explains, Visom's technology offers a way to simplify surgery and potentially help decrease errors, 75% of which occur during the surgery. Buchanan delivers an overview of how their system works, providing information on the technology. Transitioning imagery to 3D, while challenging, will provide more thorough information than the standard 2D. He explains how pre-surgical planning can be augmented by the Visom system. By utilizing 3D holograms, surgeons can really get a better grasp of what they will be doing in surgery, before the surgery begins. The technology guru talks about some of the partnerships and business relationships that they have engaged in, to expand and accelerate the use of their amazing technology. Buchanan provides information on how they are taking their technology to institutions that want to use it for training purposes. The technologist speaks in depth about the healthcare industry in general, discussing innovation. The critical data that is generated and subsequently interpreted by Visom can truly provide surgeons the insight they require and assist them in making better, more informed decisions, allowing surgeons to focus on the patient. The Visom mission is to simplify healthcare through innovative technology that is easy to use, and provide mobile surgical navigation software that can be utilized anywhere. Buchanan wraps up by talking about the future of Visom and when he expects their tech will be commercialized and opened up to the wide market in the healthcare industry.

After being diagnosed with a serious mental health condition eight years ago, Dan Seidler began to track his mood at the recommendation of his psychiatrist. The idea was that the more he could understand aspects of his experience, such as what triggers his anxiety or depression, the better he could deal with managing it, the better he could work with his mental health providers, and the better he could regulate his own behaviors in a way that could reduce his symptoms. This mood tracking practice has brought him improved self-awareness, increased happiness, and reduced stress levels. Though continuing to deal with life's struggles is unavoidable, he now has a better sense of control and knows how to implement more effective coping strategies. Seidler wants you to have access to these tools as well. He joins the podcast today to talk about his experience and his app, Misu, an automated mood tracking tool. Listen in to learn more. Misu is still in closed beta, which you can obtain access to by going to www.misu.app. If you are too excited to wait, email Seidler at dan@misu.app and he will bump you to the front of the line!

Right now, there are thousands of people who need a heart transplant, yet there are not nearly enough organs available to meet that need. Additionally, those who do receive a donor heart run the risk of rejection and must on lifelong immunosuppressants, which consequently makes them more susceptible to infection. As Dr. Jeffrey Morgan, M.D., says, with the methods we have in place today, heart transplant recipients are essentially trading one disease for another. Dr. Morgan is the Chief Medical Officer at BIOLIFE4D, a biotech company that is developing a bioartificial heart, which would increase availability of hearts for transplantation and eliminate the risk of rejection, as the heart would be generated from the patient's own cells. Press play to hear more. Be sure to visit the BIOLIFE4D website at https://biolife4d.com.